Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies

Arginine auxotrophy occurs in certain tumor types and is usually caused by the silencing of argininosuccinate synthetase 1 or arginine lyase genes. Such tumors are often associated with an intrinsic chemoresistance and thus a poor prognosis. Arginine auxotrophy however renders these tumors vulnerabl...

Full description

Bibliographic Details

Main Authors:	Christin Riess, Fatemeh Shokraie, Carl Friedrich Classen, Bernd Kreikemeyer, Tomas Fiedler, Christian Junghanss, Claudia Maletzki
Format:	Artigo
Language:	Inglês
Published:	Cell Physiol Biochem Press GmbH & Co KG 2018-11-01
Series:	Cellular Physiology and Biochemistry
Subjects:	Combination therapy Arginine-auxotrophy Arginine deiminase Therapy resistance Tumor microenvironment
Online Access:	https://www.karger.com/Article/FullText/495382
Tags:	Add Tag No Tags, Be the first to tag this record!